Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher B Granger

Showing results (391-400 of 910) with videos related to

Pageof 91
Sort By:
Circulation|September 24, 2004
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-IPadma Kaul, Paul W Armstrong, Wei-Ching Chang, et al.
American Heart Journal|September 10, 2010
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease StudySvati H Shah, Christopher B Granger, Elizabeth R Hauser, et al.
European Heart Journal|May 27, 2010
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trialKurt Huber, David R Holmes, Arnoud W van 't Hof, et al.
The American Journal of Cardiology|March 25, 2008
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practiceRaymond T Yan, Andrew T Yan, Christopher B Granger, et al.
Atherosclerosis|January 10, 2014
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterizationSayanti Bhattacharya, Christopher B Granger, Damian Craig, et al.
European Heart Journal|August 31, 2012
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trialStefan H Hohnloser, Ziad Hijazi, Laine Thomas, et al.
American Heart Journal|August 8, 2025
Medicare Coverage Gap Status, Adherence to Oral Anticoagulation, and Stroke Rates in Patients with Atrial FibrillationJosephine Harrington, Rohin K Reddy, Anthony Carnicelli, et al.
American Heart Journal|September 10, 2010
Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) studyJoel M Gore, Eric Peterson, Alpesh Amin, et al.
Cardiovascular Drugs and Therapy|September 27, 2017
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical OutcomesSøren L Kristensen, Pardeep S Jhund, Matthew M Y Lee, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Pageof 91

Showing results (391-400 of 910) with videos related to

Sort By:
Pageof 91
Circulation|September 24, 2004
Long-term mortality of patients with acute myocardial infarction in the United States and Canada: comparison of patients enrolled in Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-IPadma Kaul, Paul W Armstrong, Wei-Ching Chang, et al.
American Heart Journal|September 10, 2010
Reclassification of cardiovascular risk using integrated clinical and molecular biosignatures: Design of and rationale for the Measurement to Understand the Reclassification of Disease of Cabarrus and Kannapolis (MURDOCK) Horizon 1 Cardiovascular Disease StudySvati H Shah, Christopher B Granger, Elizabeth R Hauser, et al.
European Heart Journal|May 27, 2010
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trialKurt Huber, David R Holmes, Arnoud W van 't Hof, et al.
The American Journal of Cardiology|March 25, 2008
Usefulness of quantitative versus qualitative ST-segment depression for risk stratification of non-ST elevation acute coronary syndromes in contemporary clinical practiceRaymond T Yan, Andrew T Yan, Christopher B Granger, et al.
Atherosclerosis|January 10, 2014
Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterizationSayanti Bhattacharya, Christopher B Granger, Damian Craig, et al.
European Heart Journal|August 31, 2012
Efficacy of apixaban when compared with warfarin in relation to renal function in patients with atrial fibrillation: insights from the ARISTOTLE trialStefan H Hohnloser, Ziad Hijazi, Laine Thomas, et al.
American Heart Journal|August 8, 2025
Medicare Coverage Gap Status, Adherence to Oral Anticoagulation, and Stroke Rates in Patients with Atrial FibrillationJosephine Harrington, Rohin K Reddy, Anthony Carnicelli, et al.
American Heart Journal|September 10, 2010
Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) studyJoel M Gore, Eric Peterson, Alpesh Amin, et al.
Cardiovascular Drugs and Therapy|September 27, 2017
Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical OutcomesSøren L Kristensen, Pardeep S Jhund, Matthew M Y Lee, et al.
Critical Care Medicine|June 14, 2013
The systemic inflammatory response syndrome in patients with ST-segment elevation myocardial infarctionSean van Diepen, John P Vavalle, L Kristin Newby, et al.
Pageof 91